Home1801 • HKG
add
Innovent Biologics Inc
Nakaraang pagsara
$94.80
Sakop ng araw
$92.85 - $94.55
Sakop ng taon
$28.65 - $109.10
Market cap
159.55B HKD
Average na Volume
15.61M
P/E ratio
125.59
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.98B | 50.62% |
Gastos sa pagpapatakbo | 1.91B | 16.28% |
Net na kita | 417.16M | 312.50% |
Net profit margin | 14.01 | 241.09% |
Kita sa bawat share | — | — |
EBITDA | 514.79M | 513.71% |
Aktuwal na % ng binabayarang buwis | 7.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 9.54B | 10.56% |
Kabuuang asset | 23.59B | 16.25% |
Kabuuang sagutin | 9.17B | 16.56% |
Kabuuang equity | 14.42B | — |
Natitirang share | 1.65B | — |
Presyo para makapag-book | 10.87 | — |
Return on assets | 4.10% | — |
Return on capital | 5.43% | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 417.16M | 312.50% |
Cash mula sa mga operasyon | 156.88M | 245.51% |
Cash mula sa pag-invest | 272.40M | 198.39% |
Cash mula sa financing | 324.21M | 348.61% |
Net change in cash | 748.48M | 245.09% |
Malayang cash flow | 377.17M | 233.09% |
Tungkol
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
CEO
Itinatag
Nob 28, 2011
Website
Mga Empleyado
6,190
